Displaying drugs 3376 - 3400 of 3962 in total
7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine
Experimental
Matched Name: … 7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine …
Matched Iupac: … 7-(2,5-dihydro-1H-pyrrol-1-yl)-6-phenylpyrido[2,3-d]pyrimidin-2-amine …
Matched Iupac: … 7-(2,5-dihydro-1H-pyrrol-1-yl)-6-phenylpyrido[2,3-d]pyrimidin-2-amine …
2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL
Experimental
Matched Name: … 2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL …
Matched Iupac: … 2-{[5,6-bis(4-methoxyphenyl)furo[2,3-d]pyrimidin-4-yl]amino}ethan-1-ol …
Matched Iupac: … 2-{[5,6-bis(4-methoxyphenyl)furo[2,3-d]pyrimidin-4-yl]amino}ethan-1-ol …
Inobrodib
Investigational
Matched Synonyms: … s)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethylisoxazol-4-yl)-1-((1r,4s)-4-methoxycyclohexyl)-1h-benzo(d) …
Ulevostinag
Investigational
Matched Synonyms: … -d-arabino-adenylyl-(3'->5')-3'-deoxy-3'-fluoro-, cyclic nucleotide …
Allisartan isoproxil
Allisartan isoproxil is under investigation in clinical trial NCT03264352 (Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes).
Investigational
Matched Synonyms: … 1H-IMIDAZOLE-5-CARBOXYLIC ACID, 2-BUTYL-4-CHLORO-1-((2'-(2H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL …
S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE
Experimental
Matched Name: … S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE …
Matched Iupac: … (2-{[2-(heptanoylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-hydroxy-2,2-dimethylpropoxy]phosphinic acid …
Matched Iupac: … (2-{[2-(heptanoylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-hydroxy-2,2-dimethylpropoxy]phosphinic acid …
Calcitriol
Calcitriol is an active metabolite of vitamin D with 3 hydroxyl (OH) groups and is commonly referred to as 1,25-dihydroxycholecalciferol, or 1alpha,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D3. It is produced in the body after series of conversion steps of 7-dehydrocholesterol from exposure to UV light. 7-dehydrocholesterol is converted to DB00169 (vitamin D3)...
Approved
Nutraceutical
Matched Synonyms: … 1-alpha-25-Dihydroxyvitamin D3 ... 1α,25-dihydroxyvitamin D3 …
Matched Description: … In addition to promoting fatty acid synthesis and inhibiting lipolysis, calcitriol has been demonstrated ... reabsorption of calcium in the kidneys, and stimulating the release of calcium stores from the skeletal ... Calcitriol is an active metabolite of vitamin D with 3 hydroxyl (OH) groups and is commonly referred …
Matched Categories: … Vitamin D and Analogues ... Calcium-Regulating Hormones and Agents ... Alimentary Tract and Metabolism ... Diet, Food, and Nutrition ... Skin and Mucous Membrane Agents …
Matched Products: … CALCITRIOLO DOC GENERICI ... ROCALTROL CAPSULAS DE GELATINA BLANDA0.25MCG ... ROCALTROL® 0.50 CÁPSULAS DE GELATINA BLANDA 0.50 MCG. …
Matched Description: … In addition to promoting fatty acid synthesis and inhibiting lipolysis, calcitriol has been demonstrated ... reabsorption of calcium in the kidneys, and stimulating the release of calcium stores from the skeletal ... Calcitriol is an active metabolite of vitamin D with 3 hydroxyl (OH) groups and is commonly referred …
Matched Categories: … Vitamin D and Analogues ... Calcium-Regulating Hormones and Agents ... Alimentary Tract and Metabolism ... Diet, Food, and Nutrition ... Skin and Mucous Membrane Agents …
Matched Products: … CALCITRIOLO DOC GENERICI ... ROCALTROL CAPSULAS DE GELATINA BLANDA0.25MCG ... ROCALTROL® 0.50 CÁPSULAS DE GELATINA BLANDA 0.50 MCG. …
Cangrelor
Cangrelor is an intravenous, direct-acting, reversible P2Y12 inhibitor for patients undergoing percutaneous coronary intervention (PCI) who have not been yet treated by oral P2Y12 inhibitors. An advantage Cangrelor provides over oral P2Y12 inhibitors (such as prasugrel, ticagrelor, and clopidogrel) is that it is an active drug not requiring metabolic conversion...
Approved
Matched Synonyms: … trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid …
Matched Iupac: … sulfanyl]-9H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl})methyl]phosphonic acid …
Matched Description: … An advantage Cangrelor provides over oral P2Y12 inhibitors (such as prasugrel, ticagrelor, and clopidogrel ... ) is that it is an active drug not requiring metabolic conversion therefore providing a rapid onset and …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides ... Blood and Blood Forming Organs …
Matched Iupac: … sulfanyl]-9H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl})methyl]phosphonic acid …
Matched Description: … An advantage Cangrelor provides over oral P2Y12 inhibitors (such as prasugrel, ticagrelor, and clopidogrel ... ) is that it is an active drug not requiring metabolic conversion therefore providing a rapid onset and …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides ... Blood and Blood Forming Organs …
TH-9402 free base
Investigational
Matched Synonyms: … Benzoic acid, 2-(6-amino-4,5-dibromo-3-imino-3h-xanthen-9-yl)-, methyl ester …
Efocipegtrutide
Efocipegtrutide is a long-acting, monomeric peptide triple agonist.
Investigational
Matched Synonyms: … GAMMA.4-CHAIN C REGION C-TERMINAL FRAGMENT), DIMER, 1-(1-(3-HYDROXYPROPYL)-L-PROLINE), 1-ETHER WITH .ALPHA …
2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid
Experimental
Matched Name: … 2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid …
Matched Iupac: … (2S,3S,6R,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecanoic acid …
Matched Iupac: … (2S,3S,6R,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecanoic acid …
(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid
(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is a solid. This compound belongs to the indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2.
Experimental
Matched Name: … (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid …
Matched Iupac: … (2R)-2-(1H-indol-3-yl)-2-[(2-sulfanylethoxy)amino]acetic acid …
Matched Description: … (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is a solid. ... This compound belongs to the indole-3-acetic acid derivatives. ... . (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2. …
Matched Iupac: … (2R)-2-(1H-indol-3-yl)-2-[(2-sulfanylethoxy)amino]acetic acid …
Matched Description: … (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is a solid. ... This compound belongs to the indole-3-acetic acid derivatives. ... . (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2. …
N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid
N(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar.
Experimental
Matched Name: … N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid …
Matched Iupac: … 4-({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)butanoic acid …
Matched Description: … This compound belongs to the purine nucleosides and analogues. ... N(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid is a solid. …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Amino Acids ... Acids, Acyclic ... Carboxylic Acids …
Matched Iupac: … 4-({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)amino)butanoic acid …
Matched Description: … This compound belongs to the purine nucleosides and analogues. ... N(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid is a solid. …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Amino Acids ... Acids, Acyclic ... Carboxylic Acids …
3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid
Experimental
Matched Name: … 3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid …
Matched Iupac: … 3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid …
Matched Iupac: … 3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid …
3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid
Experimental
Matched Name: … 3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid …
Matched Iupac: … 3-{[(Z)-[(2-methoxyphenyl)methylidene]amino]oxy}propanoic acid …
Matched Iupac: … 3-{[(Z)-[(2-methoxyphenyl)methylidene]amino]oxy}propanoic acid …
(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID
Experimental
Matched Name: … (3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID …
Matched Iupac: … (3R)-4,4-difluoro-3-(4-methoxybenzenesulfonyl)butanoic acid …
Matched Iupac: … (3R)-4,4-difluoro-3-(4-methoxybenzenesulfonyl)butanoic acid …
5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID
Experimental
Matched Name: … 5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID …
Matched Iupac: … 5-bromo-2-(4-chlorobenzenesulfonamido)benzoic acid …
Matched Iupac: … 5-bromo-2-(4-chlorobenzenesulfonamido)benzoic acid …
2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID
Experimental
Matched Name: … 2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID …
Matched Iupac: … 2-[(1E)-2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzoic acid …
Matched Iupac: … 2-[(1E)-2-(4-hydroxy-3,5-dimethylphenyl)diazen-1-yl]benzoic acid …
(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid
Experimental
Matched Name: … (3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid …
Matched Iupac: … (3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid …
Matched Iupac: … (3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid …
[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID
Experimental
Matched Name: … [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID …
Matched Iupac: … 2-[4-(4-phenylpiperidin-1-yl)benzenesulfonamido]acetic acid …
Matched Iupac: … 2-[4-(4-phenylpiperidin-1-yl)benzenesulfonamido]acetic acid …
(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)
Experimental
Matched Name: … (6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID) …
Matched Iupac: … [(6E,11E)-9-phosphonoheptadeca-6,11-dien-9-yl]phosphonic acid …
Matched Iupac: … [(6E,11E)-9-phosphonoheptadeca-6,11-dien-9-yl]phosphonic acid …
Ziltivekimab
Ziltivekimab is under investigation in clinical trial NCT06200207 (A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation).
Investigational
Matched Synonyms: … Immunoglobulin g1 (255-tyrosine,257-threonine,259-glutamic acid), anti-(human interleukin 6) (human monoclonal …
Matched Description: … Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Description: … Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Elvitegravir
Elvitegravir is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) used for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. Because integrase is necessary for viral replication, inhibition prevents the integration of HIV-1 DNA into the host genome and thereby blocks the formation of the...
Approved
Matched Synonyms: … fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Matched Iupac: … fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Matched Description: … into the host genome and thereby blocks the formation of the HIV-1 provirus and resulting propagation ... Elvitegravir was first licensed from Japan Tobacco in 2008 and developed by Gilead Sciences. ... elvitegravir must be used in combination with an HIV protease inhibitor coadministered with ritonavir and …
Matched Categories: … emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat ... emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat …
Matched Iupac: … fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Matched Description: … into the host genome and thereby blocks the formation of the HIV-1 provirus and resulting propagation ... Elvitegravir was first licensed from Japan Tobacco in 2008 and developed by Gilead Sciences. ... elvitegravir must be used in combination with an HIV protease inhibitor coadministered with ritonavir and …
Matched Categories: … emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat ... emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat …
1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide
Experimental
Matched Name: … 1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide …
Matched Iupac: … N-benzyl-1-ethyl-4-[(oxan-4-yl)amino]-1H-pyrazolo[3,4-b]pyridine-5-carboxamide …
Matched Iupac: … N-benzyl-1-ethyl-4-[(oxan-4-yl)amino]-1H-pyrazolo[3,4-b]pyridine-5-carboxamide …
4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
Experimental
Matched Name: … 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid …
Matched Iupac: … 4-[2,4-bis(3-nitrobenzamido)phenoxy]benzene-1,2-dicarboxylic acid …
Matched Iupac: … 4-[2,4-bis(3-nitrobenzamido)phenoxy]benzene-1,2-dicarboxylic acid …
Displaying drugs 3376 - 3400 of 3962 in total